Source link : https://www.newshealth.biz/health-news/guselkumab-efficacy-in-cd-unaffected-by-prior-biologic-use/
VIENNA — Guselkumab has been shown to be efficacious vs placebo in patients with moderately to severely active Crohn’s disease (CD), regardless of prior biologic therapy exposure, according to a pooled analysis of the two phase 3 double-blind GALAXI 2 and 3 studies. We found that guselkumab was effective in both biologic-naive and biologic-inadequate subpopulations, […]
Author : News Health
Publish date : 2024-10-22 07:40:16
Copyright for syndicated content belongs to the linked Source.